You searched for infectious diseases | Page 4 of 295

Optimized Pooled Testing Cuts Costs for Infectious Disease Screening

Researchers developed an optimized pooled testing framework, enabling faster, cost-effective, and accurate infectious disease screening.

Delve Bio’s Delve Detect is a metagenomic sequencing test capable of quickly identifying over 68,000 pathogens from CSF.

Posted by Andy Lundin | Sep 4, 2024 | Company News |

QIAGEN and AstraZeneca will develop a genotyping assay for companion diagnostics, advancing testing for therapies targeting chronic diseases.

The Karius Test, a diagnostic tool for lung infections in immunocompromised patients, received Breakthrough Device Designation from the FDA.

Delve Bio announced data on the use of mNGS for the definitive diagnosis of infectious causes of meningitis and/or encephalitis.